Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Adimab Announces Antibody Discovery Collaboration with Boehringer Ingelheim

Thursday, January 11, 2018

Adimab LLC the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies today announced a multitarget partnership with Boehringer Ingelheim BI Under the terms of the agreement Adimab will use its proprietary...

GT Biopharma Announces Completion of Dosing in Phase 1 Clinical Trial of GTP-004 for Myasthenia Gravis

Wednesday, January 10, 2018

GT Biopharma Inc and announced that it has completed dosing in its Phase clinical trial for GTP its promising treatment for the symptoms of myasthenia gravis The results provide evidence that GTP enables the safe and welltolerated administration of...

Syapse Enters Strategic Collaboration with Roche to Advance Precision Medicine in Oncology

Wednesday, January 10, 2018

Syapse a leading precision medicine company announced today it has entered into a multiyear strategic collaboration with Roche to make precision medicine a reality for more cancer patients and their healthcare providers Syapse and Roche will work...

Mallinckrodt Will Sell RECOTHROM® And PREVELEAK® To Baxter

Tuesday, January 09, 2018

Mallinckrodt plc a leading specialty pharmaceutical company announced today it has entered into an agreement under which it will sell certain hemostasis products to Baxter International Inc NYSE BAX for approximately million with upfront payment of...

Intec Pharma Announces Development Collaboration With Global Pharmaceutical Company

Tuesday, January 09, 2018

Intec Pharma Ltd a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology today announced it has entered into a Feasibility and Option agreement with Novartis Pharmaceuticals t...

Celgene to Acquire Impact Biomedicines, Adding Fedratinib to Its Pipeline of Novel Therapies for Hematologic Malignancies

Monday, January 08, 2018

Celgene Corporation and Impact Biomedicines today announced the signing of a definitive agreement in which Celgene will acquire Impact Biomedicines which is developing fedratinib for myelofibrosis and polycythemia vera Under the terms of the agreemen...

Alnylam and Sanofi Enter into Strategic Restructuring of RNAi Therapeutics Rare Disease Alliance

Monday, January 08, 2018

Alnylam Pharmaceuticals Inc the leading RNAi therapeutics company and Sanofi announced today a strategic restructuring of their RNAi therapeutics alliance to streamline and optimize development and commercialization of certain products for the treatm...

Takeda and Denali Therapeutics Collaborate to Develop and Commercialize Therapies for Neurodegenerative Diseases

Saturday, January 06, 2018

Takeda Pharmaceutical Company Limited and Denali Therapeutics today announced that they have entered into a strategic option and collaboration agreement to develop and commercialize up to three specified therapeutic product candidates for neurodegene...

Servier and Treventis begin strategic research partnership in neurodegenerative diseases

Friday, January 05, 2018

Servier and Treventis announce strategic research partnership in targeting misfolded proteins implicated in neurodegenerative diseases The collaboration covers a large drug discovery program targeting both tau and amylode A two key proteins involved...

AvantGen and Tanabe Research Laboratories Expand Collaboration for Therapeutic Antibody Discovery

Friday, January 05, 2018

AvantGen Inc a privatelyheld antibody discovery and optimization service provider today announced the successful completion of a first cancer therapeutic antibody discovery program and initiation of a second program for Tanabe Research Laboratories U...